Clinica Universitaria Privada Reina Fabiola
Córdoba 5000CRD
1 studies enrolling now · 3 studies all time
What they study most
Breast Cancer, Cancer, Gastric Cancer, Gastroesophageal Junction Cancer
Studies at this site
- Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer — Recruiting now
- E7389 Versus Treatment of Physician's Choice in Patients With Locally Recurrent or Metastatic Breast Cancer — Completed
- Phase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer — Completed